Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis

Traci M. Kazmerski, Gregory S. Sawicki, Elizabeth Miller, Kelley A. Jones, Kaleab Z. Abebe, Lisa K. Tuchman, Sigrid Ladores, Ronald C. Rubenstein, Scott D. Sagel, Daniel J. Weiner, Joseph M. Pilewski, David M. Orenstein, Sonya Borrero

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: This study aimed to describe and compare the sexual and reproductive health (SRH) care utilization among young women with cystic fibrosis (CF) with the general United States (U.S.) population. Methods: Women with CF ages 15-24. years from five geographically diverse U.S. CF centers participated in a survey investigating SRH. Results were summarized and compared to a nationally representative sample of young women aged 15-24 who participated in the U.S. National Survey of Family Growth (NSFG) using logistic regression to adjust for confounders. Results: A total of 188 women with CF (19.7. ±. 2.7. years) completed the survey; data were compared to 1997 NSFG respondents (19.6. ±. 0.10. years). Women with CF had lower lifetime rates of ever obtaining a Pap smear or pelvic exam (26% vs. 57%; p <. 0.001) and similar rates of HPV vaccination (44% vs. 43%; p = 0.64) compared to NSFG respondents. Thirty-seven percent of women with CF reported seeking contraception and <. 10% reported contraceptive counseling, STI testing/counseling, or pregnancy testing in their lifetime. In the prior 12. months, 41% of NSFG respondents reported seeking contraception, 24% received contraceptive counseling, 22% STI testing/counseling, and 23% pregnancy testing. A minority of women with CF received or discussed SRH care in the CF setting, although 66% wanted to discuss SRH with their CF team. Conclusions: Young women with CF report low rates of SRH care utilization and desire SRH discussions in the CF setting. Interventions should target improved SRH care delivery and encourage patient-provider communication around SRH in the CF care setting.

Original languageEnglish (US)
JournalJournal of Cystic Fibrosis
DOIs
StateAccepted/In press - 2017
Externally publishedYes

Fingerprint

Patient Acceptance of Health Care
Reproductive Health
Cystic Fibrosis
Counseling
Growth
Sexually Transmitted Diseases
Contraceptive Agents
Contraception
Delivery of Health Care
Surveys and Questionnaires
Papanicolaou Test
Pregnancy
Gynecological Examination

Keywords

  • Cystic fibrosis
  • Sexual and reproductive health
  • Women's health

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Kazmerski, T. M., Sawicki, G. S., Miller, E., Jones, K. A., Abebe, K. Z., Tuchman, L. K., ... Borrero, S. (Accepted/In press). Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2017.08.009

Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis. / Kazmerski, Traci M.; Sawicki, Gregory S.; Miller, Elizabeth; Jones, Kelley A.; Abebe, Kaleab Z.; Tuchman, Lisa K.; Ladores, Sigrid; Rubenstein, Ronald C.; Sagel, Scott D.; Weiner, Daniel J.; Pilewski, Joseph M.; Orenstein, David M.; Borrero, Sonya.

In: Journal of Cystic Fibrosis, 2017.

Research output: Contribution to journalArticle

Kazmerski, TM, Sawicki, GS, Miller, E, Jones, KA, Abebe, KZ, Tuchman, LK, Ladores, S, Rubenstein, RC, Sagel, SD, Weiner, DJ, Pilewski, JM, Orenstein, DM & Borrero, S 2017, 'Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis', Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2017.08.009
Kazmerski, Traci M. ; Sawicki, Gregory S. ; Miller, Elizabeth ; Jones, Kelley A. ; Abebe, Kaleab Z. ; Tuchman, Lisa K. ; Ladores, Sigrid ; Rubenstein, Ronald C. ; Sagel, Scott D. ; Weiner, Daniel J. ; Pilewski, Joseph M. ; Orenstein, David M. ; Borrero, Sonya. / Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis. In: Journal of Cystic Fibrosis. 2017.
@article{17cba14a9f544a128205587ac0d56585,
title = "Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis",
abstract = "Background: This study aimed to describe and compare the sexual and reproductive health (SRH) care utilization among young women with cystic fibrosis (CF) with the general United States (U.S.) population. Methods: Women with CF ages 15-24. years from five geographically diverse U.S. CF centers participated in a survey investigating SRH. Results were summarized and compared to a nationally representative sample of young women aged 15-24 who participated in the U.S. National Survey of Family Growth (NSFG) using logistic regression to adjust for confounders. Results: A total of 188 women with CF (19.7. ±. 2.7. years) completed the survey; data were compared to 1997 NSFG respondents (19.6. ±. 0.10. years). Women with CF had lower lifetime rates of ever obtaining a Pap smear or pelvic exam (26{\%} vs. 57{\%}; p <. 0.001) and similar rates of HPV vaccination (44{\%} vs. 43{\%}; p = 0.64) compared to NSFG respondents. Thirty-seven percent of women with CF reported seeking contraception and <. 10{\%} reported contraceptive counseling, STI testing/counseling, or pregnancy testing in their lifetime. In the prior 12. months, 41{\%} of NSFG respondents reported seeking contraception, 24{\%} received contraceptive counseling, 22{\%} STI testing/counseling, and 23{\%} pregnancy testing. A minority of women with CF received or discussed SRH care in the CF setting, although 66{\%} wanted to discuss SRH with their CF team. Conclusions: Young women with CF report low rates of SRH care utilization and desire SRH discussions in the CF setting. Interventions should target improved SRH care delivery and encourage patient-provider communication around SRH in the CF care setting.",
keywords = "Cystic fibrosis, Sexual and reproductive health, Women's health",
author = "Kazmerski, {Traci M.} and Sawicki, {Gregory S.} and Elizabeth Miller and Jones, {Kelley A.} and Abebe, {Kaleab Z.} and Tuchman, {Lisa K.} and Sigrid Ladores and Rubenstein, {Ronald C.} and Sagel, {Scott D.} and Weiner, {Daniel J.} and Pilewski, {Joseph M.} and Orenstein, {David M.} and Sonya Borrero",
year = "2017",
doi = "10.1016/j.jcf.2017.08.009",
language = "English (US)",
journal = "Journal of Cystic Fibrosis",
issn = "1569-1993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis

AU - Kazmerski, Traci M.

AU - Sawicki, Gregory S.

AU - Miller, Elizabeth

AU - Jones, Kelley A.

AU - Abebe, Kaleab Z.

AU - Tuchman, Lisa K.

AU - Ladores, Sigrid

AU - Rubenstein, Ronald C.

AU - Sagel, Scott D.

AU - Weiner, Daniel J.

AU - Pilewski, Joseph M.

AU - Orenstein, David M.

AU - Borrero, Sonya

PY - 2017

Y1 - 2017

N2 - Background: This study aimed to describe and compare the sexual and reproductive health (SRH) care utilization among young women with cystic fibrosis (CF) with the general United States (U.S.) population. Methods: Women with CF ages 15-24. years from five geographically diverse U.S. CF centers participated in a survey investigating SRH. Results were summarized and compared to a nationally representative sample of young women aged 15-24 who participated in the U.S. National Survey of Family Growth (NSFG) using logistic regression to adjust for confounders. Results: A total of 188 women with CF (19.7. ±. 2.7. years) completed the survey; data were compared to 1997 NSFG respondents (19.6. ±. 0.10. years). Women with CF had lower lifetime rates of ever obtaining a Pap smear or pelvic exam (26% vs. 57%; p <. 0.001) and similar rates of HPV vaccination (44% vs. 43%; p = 0.64) compared to NSFG respondents. Thirty-seven percent of women with CF reported seeking contraception and <. 10% reported contraceptive counseling, STI testing/counseling, or pregnancy testing in their lifetime. In the prior 12. months, 41% of NSFG respondents reported seeking contraception, 24% received contraceptive counseling, 22% STI testing/counseling, and 23% pregnancy testing. A minority of women with CF received or discussed SRH care in the CF setting, although 66% wanted to discuss SRH with their CF team. Conclusions: Young women with CF report low rates of SRH care utilization and desire SRH discussions in the CF setting. Interventions should target improved SRH care delivery and encourage patient-provider communication around SRH in the CF care setting.

AB - Background: This study aimed to describe and compare the sexual and reproductive health (SRH) care utilization among young women with cystic fibrosis (CF) with the general United States (U.S.) population. Methods: Women with CF ages 15-24. years from five geographically diverse U.S. CF centers participated in a survey investigating SRH. Results were summarized and compared to a nationally representative sample of young women aged 15-24 who participated in the U.S. National Survey of Family Growth (NSFG) using logistic regression to adjust for confounders. Results: A total of 188 women with CF (19.7. ±. 2.7. years) completed the survey; data were compared to 1997 NSFG respondents (19.6. ±. 0.10. years). Women with CF had lower lifetime rates of ever obtaining a Pap smear or pelvic exam (26% vs. 57%; p <. 0.001) and similar rates of HPV vaccination (44% vs. 43%; p = 0.64) compared to NSFG respondents. Thirty-seven percent of women with CF reported seeking contraception and <. 10% reported contraceptive counseling, STI testing/counseling, or pregnancy testing in their lifetime. In the prior 12. months, 41% of NSFG respondents reported seeking contraception, 24% received contraceptive counseling, 22% STI testing/counseling, and 23% pregnancy testing. A minority of women with CF received or discussed SRH care in the CF setting, although 66% wanted to discuss SRH with their CF team. Conclusions: Young women with CF report low rates of SRH care utilization and desire SRH discussions in the CF setting. Interventions should target improved SRH care delivery and encourage patient-provider communication around SRH in the CF care setting.

KW - Cystic fibrosis

KW - Sexual and reproductive health

KW - Women's health

UR - http://www.scopus.com/inward/record.url?scp=85028513002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028513002&partnerID=8YFLogxK

U2 - 10.1016/j.jcf.2017.08.009

DO - 10.1016/j.jcf.2017.08.009

M3 - Article

AN - SCOPUS:85028513002

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

SN - 1569-1993

ER -